Calendar

pharmadog

Week of Jan 26, 2026

Jan 29, 2026approval195d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 29, 2026approval195d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Jan 29, 2026approval195d agoRIZAFILM (RIZATRIPTAN BENZOATE) — FDA approvalNAL Pharmaceuticals Ltd

Sponsor: GENSCO. Form: FILM. Route: ORAL

full page →fda approvals ↗

Jan 29, 2026approval195d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL

full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗

Jan 29, 2026approval195d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: RISING. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Jan 29, 2026approval195d agoRILPIVIRINE HYDROCHLORIDE — FDA approvalrilpivirine hydrochloride ODT

Sponsor: SOMERSET THERAPS LLC. Form: TABLET. Route: ORAL

full page →rilpivirine hydrochloride ODT →fda approvals ↗

Jan 29, 2026approval195d agoLACOSAMIDE — FDA approvalAucta Pharmaceuticals Inc

Sponsor: REGCON HOLDINGS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Jan 29, 2026approval195d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

Jan 29, 2026approval195d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

Jan 29, 2026approval195d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Jan 29, 2026approval195d agoXIMINO (MINOCYCLINE HYDROCHLORIDE) — FDA approvalOraPharma Inc

Sponsor: JOURNEY. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 29, 2026approval195d agoLORBRENA (LORLATINIB) — FDA approvallorlatinib

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →lorlatinib →fda approvals ↗

Jan 29, 2026approval195d agoPRUCALOPRIDE SUCCINATE — FDA approvalPRUCALOPRIDE SUCCINATE

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →PRUCALOPRIDE SUCCINATE →fda approvals ↗

Jan 29, 2026grant195d agoUNIVERSITY OF PENNSYLVANIA — Organizational Changes to Reduce Nurse BurnoutUniversity of Pennsylvania

NR grant. $2,009,207. PI: Karen Blanchette Lasater

full page →nih reporter ↗

Jan 29, 2026grant195d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — The role of CD69 in established resident memory T cellsNew York University

AI grant. $466,125. PI: Susan Ruth Schwab

full page →nih reporter ↗

Jan 29, 2026grant195d agoUNIVERSITY OF NEBRASKA MEDICAL CENTER — Interplay Between Transcription and ATP-dependent Chromatin Remodeling for Ge...

GM grant. $280,905. PI: Sandipan Brahma

full page →nih reporter ↗

Jan 30, 2026approval194d agoZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval194d agoBRIVARACETAM — FDA approvalUCB SA

Sponsor: SUNSHINE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval194d agoBRIVARACETAM — FDA approvalUCB SA

Sponsor: SUNSHINE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval194d agoZYPREXA RELPREVV (OLANZAPINE PAMOATE) — FDA approvalCHEPLAPHARM Arzneimittel GmbH

Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →fda approvals ↗

Jan 30, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Jan 30, 2026approval194d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval194d agoARSENIC TRIOXIDE — FDA approvalQuetzal Therapeutics LLC

Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Jan 30, 2026approval194d agoEPIRUBICIN HYDROCHLORIDE — FDA approvalEPIRUBICIN HYDROCHLORIDE

Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION

full page →EPIRUBICIN HYDROCHLORIDE →fda approvals ↗

Jan 30, 2026approval194d agoAMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalHikma Pharmaceuticals Plc

Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval194d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval194d agoLIVDELZI (SELADELPAR LYSINE) — FDA approvalseladelpar lysine

Sponsor: GILEAD SCIENCES INC. Form: CAPSULE. Route: ORAL

full page →seladelpar lysine →fda approvals ↗

Jan 30, 2026approval194d agoLATANOPROST — FDA approvalXalatan

Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Jan 30, 2026approval194d agoLATANOPROST — FDA approvalXalatan

Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Jan 30, 2026approval194d agoLATANOPROST — FDA approvalXalatan

Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Jan 30, 2026approval194d agoEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE) — FDA approvalemtricitabine

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →emtricitabine →fda approvals ↗

Jan 30, 2026approval194d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

full page →fda approvals ↗

Jan 30, 2026approval194d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE